Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Emergent BioSolutions Inc. Common Stock (NY:EBS)

8.000 -0.140 (-1.72%)
Official Closing Price Updated: 7:00 PM EDT, Sep 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Emergent BioSolutions Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Why Emergent BioSolutions Stock Blasted Higher Today
Via The Motley Fool
Nasdaq Down Over 100 Points; US Pending Home Sales Increase In November
 
Via Benzinga
Crude Oil Gains 1%; Chicago PMI Falls In December
 
Via Benzinga
Cytek Biosciences, Emergent BioSolutions, Radiopharm Theranostics And Other Big Stocks Moving Higher On Monday
 
Via Benzinga
This Nuvalent Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
 
Via Benzinga
War On Drugs 'Has Failed, Completely And Utterly': UN High Commissioner Urges Evidence-Based Solutions
UN calls for evidence-based, human rights-focused approach to drug policies, declaring the failed war on drugs needs to be abandoned. Urges transformative change and adoption of International... 
Via Benzinga
Why Emergent BioSciences Stock Plummeted Today
Via The Motley Fool
Emergent's Vaccine Production Failure: Contamination Scandal, Investor Backlash, and $40M Settlement
 
Via Benzinga
From GLD To TSLA: Unlocking Today’s Best Trading Opportunities
The week kicks off amidst significant market movements shaped by geopolitical and policy developments. 
Via Talk Markets
Topics Stocks / Equities
After Trump's Win, It's Time To Take Profits On Gold
 
Via Benzinga
Topics Government
Overdose Crisis In Shadows Of Elections As Black, Indigenous Americans Deaths Rise
The U.S. overdose crisis and its racial disparities were overlooked in the election, as Black and Indigenous Americans face rising death rates. 
Via Benzinga
Topics Death
Mpox Vaccine Player Emergent BioSolutions Stock Jumps On Upbeat Annual Forecast, Expects Smaller Losses In 2024
Emergent BioSolutions stock rises on mixed Q3 results, improved 2024 guidance, and news of a new trial for mpox treatment in Africa led by the CDC. 
Via Benzinga
Crude Oil Rises 1%; US Jobless Claims Increase To 221,000
 
Via Benzinga
Gold Gains 1%; Halliburton Posts Weak Q3 Results
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
HubSpot Posts Better-Than-Expected Results, Joins Under Armour, Lyft, Wolverine World Wide, Zillow And Other Big Stocks Moving Higher On Thursday
 
Via Benzinga
The Post-Trump Victory Trade
The Trump Trade. 
Via Benzinga
Topics Government
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
Why Lyft Shares Are Trading Higher By Over 21%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Emergent BioSolutions (EBS) Q3 2024 Earnings Call Transcript
EBS earnings call for the period ending September 30, 2024. 
Via The Motley Fool
Topics Earnings
What's Going On With Emergent BioSolutions Stock Wednesday?
Emergent BioSolutions stock is trading higher after the company announced the closing of a $100 million asset-backed revolving loan facility. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
Emergent BioSolutions Confirms Orders Worth $400M Related To Smallpox, Mpox Vaccines
Emergent BioSolutions secures $400M in orders for smallpox and mpox products, receives FDA approval for ACAM2000's expanded use, and updates its 2024 revenue forecast while beating Q2 sales estimates. 
Via Benzinga
Methanex, Merck And Other Big Stocks Moving Lower In Monday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
Emergent BioSolutions Stock Storms Higher After The FDA Signs Off On Mpox Vaccine
Emergent BioSolutions stock jumped early Friday. 
Via Investor's Business Daily
Mpox Vaccine: Emergent BioSolutions' Smallpox Vaccine Gets FDA Nod For Expanded Use For Individuals At High Risk Of Mpox Infection
The FDA has approved Emergent BioSolutions' supplemental Biologics License Application for ACAM2000 to include the prevention of mpox disease in high-risk individuals, with the approval based on human... 
Via Benzinga
Why MongoDB Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
WHO Seeks $135M In Funding To Fight Mpox: Outbreak 'Can Be Controlled, And Can Be Stopped'
To fight the mpox outbreak in Africa, the World Health Organization calls for funding help for its six-month plan. 
Via Benzinga
Macy's Reports Weak Sales, Joins JD.com And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.